Oliver Dolan, Senior Vice President, Finance at Korro Bio, Inc. (KRRO), sold 7,353 shares at $13.51 ($99K) on 2026-09-08, disclosed to the SEC on 2026-09-10.
Scheduled sale ($99k) by Senior Vice President, Finance under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.51 | 7,347 | $99K | 99.9% |
| 2 | $13.60 | 6 | $82 | 0.1% |
| Total | $13.51 avg | 7,353 | $99K | 100% |
| Filing → |